Evaluation of hematopoietic stem cell donors
- PMID: 16304422
- DOI: 10.1182/asheducation-2005.1.469
Evaluation of hematopoietic stem cell donors
Abstract
Donation of hematopoietic stem cells, either through bone marrow or peripheral blood collection, is a generally safe procedure for healthy donors. Serious adverse events are uncommon and death is exceedingly rare. Nevertheless, all donors must be carefully evaluated and fully informed prior to donation. This should be done by clinicians having good understanding of the potential physical and psychological complications of donation and the factors that may increase these risks. Additionally, donors and graft products must be evaluated for the potential to transmit infections and other diseases to the recipient and to satisfy an increasing number of national and international regulatory requirements. Donors must be able to provide informed consent without coercion or pressure. Special attention to the clinical, psychological and social needs of pediatric donors is necessary.
Similar articles
-
[Collection of hematopoietic progenitor cells from healthy donors].Acta Med Croatica. 2009 Jun;63(3):237-44. Acta Med Croatica. 2009. PMID: 19827352 Review. Croatian.
-
Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.Pediatr Blood Cancer. 2006 Apr;46(4):422-33. doi: 10.1002/pbc.20708. Pediatr Blood Cancer. 2006. PMID: 16411207 Review.
-
Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.Biol Blood Marrow Transplant. 2016 Jan;22(1):96-103. doi: 10.1016/j.bbmt.2015.08.017. Epub 2015 Aug 22. Biol Blood Marrow Transplant. 2016. PMID: 26307344 Review.
-
Hematopoietic stem cell donation.Int J Hematol. 2013 Apr;97(4):446-55. doi: 10.1007/s12185-013-1298-8. Epub 2013 Feb 19. Int J Hematol. 2013. PMID: 23420184 Review.
-
Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.Bone Marrow Transplant. 2003 Apr;31(7):539-45. doi: 10.1038/sj.bmt.1703851. Bone Marrow Transplant. 2003. PMID: 12692618
Cited by
-
Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.Bone Marrow Transplant. 2014 Jul;49(7):880-6. doi: 10.1038/bmt.2014.67. Epub 2014 Apr 7. Bone Marrow Transplant. 2014. PMID: 24710563
-
Hematopoietic stem cell donation in children: a review of the sibling donor experience.J Psychosoc Oncol. 2007;25(1):45-66. doi: 10.1300/J077v25n01_03. J Psychosoc Oncol. 2007. PMID: 17360315 Free PMC article. Review.
-
Addition of plerixafor in poorly mobilized allogeneic stem cell donors.J Clin Apher. 2022 Aug;37(4):388-394. doi: 10.1002/jca.21992. Epub 2022 May 28. J Clin Apher. 2022. PMID: 35633513 Free PMC article.
-
General principles regarding the use of adult stem cells.Cell Prolif. 2008 Feb;41 Suppl 1(Suppl 1):78-84. doi: 10.1111/j.1365-2184.2008.00482.x. Cell Prolif. 2008. PMID: 18181949 Free PMC article.
-
The Nationwide Children's Hospital Blood and Marrow Transplant Index: A Quality Improvement Approach to Assess the Performance of a Pediatric Blood and Marrow Transplant Program.Pediatr Qual Saf. 2025 Apr 30;10(3):e811. doi: 10.1097/pq9.0000000000000811. eCollection 2025 May-Jun. Pediatr Qual Saf. 2025. PMID: 40308535 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical